oxaliplatin

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 61825-94-3

Where It Comes From

25 FDA-registered drug labelers
Accord Healthcare Inc.
Apotex Corp.
Baxter Healthcare Corporation
BluePoint Laboratories
Camber Pharmaceuticals, Inc.
Eugia US LLC
FOSUN PHARMA USA INC.
Fresenius Kabi USA, LLC
Gland Pharma Limited
Heraeus Precious Metals GmbH & Co. KG
Hetero Labs Limited
Hospira, Inc.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Meitheal Pharmaceuticals Inc.
Mylan Institutional LLC
NorthStar Rx LLC
Qilu Pharmaceutical Co. Ltd.
Sagent Pharmaceuticals
Sandoz Inc
SHILPA PHARMA LIFESCIENCES LIMITED
Sicor de Mexico S.A. de C.V
SUN PHARMACEUTICAL INDUSTRIES, INC.
Umicore Argentina S.A.
Veranova, L.P.
Winthrop U.S, a business of sanofi-aventis U.S. LLC

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • Oxaliplatin
FDA Shortage Status
No Shortage
Shortage History
to be discontinued

Oxaliplatin Injection

10/20/2025

to be discontinued

Oxaliplatin Injection

02/25/2026

Chemical Identity

CAS61825-94-3
PubChem CID9887053
DTXSIDDTXSID0036760
FormulaC8H14N2O4Pt
Mol. Weight397.29 g/mol
SMILESC1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]

Data Sources

98870532026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/oxaliplatin/cids/JSON

Archive: data/sources/pubchem_name/oxaliplatin.json

CAS 61825-94-32026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 61825-94-32026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json